SEP 7, 2026 · JOURNAL ARTICLE
Immunotherapy in advanced biliary tract cancer: current status and future directions
Frontiers in Pharmacology
A narrative review synthesizing current evidence on immunotherapy in advanced biliary tract cancer, highlighting established standards (TOPAZ-1, KEYNOTE-966), emerging biomarkers, and investigational approaches rather than reporting original trial results.